There are 594 resources available
Cons
Presenter: Nan Wu
Session: Invasive mediastinal re-staging after Chemo-IO neoadjuvant therapy: Pros and cons
Resources:
Slides
Webcast
Second vote and conclusions/discussion
Presenter: Paul van Schil
Session: Invasive mediastinal re-staging after Chemo-IO neoadjuvant therapy: Pros and cons
Resources:
Slides
Webcast
4O - Amivantamab plus lazertinib vs osimertinib in first-line (1L) EGFR-mutant (EGFRm) advanced NSCLC: Final overall survival (OS) from the phase III MARIPOSA study
Presenter: James Chih-Hsin Yang
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Lung cancer screening: How to select the target population
Presenter: Witold Rzyman
Session: Lung cancer screening
Resources:
Slides
Webcast
Emerging therapeutics for intracranial metastases in oncogene-driven non-small cell lung cancer
Presenter: Xiuning Le
Session: Innovation in actionable genomic alterations (AGA)
Resources:
Slides
Webcast
Invited Discussant 4O
Presenter: Maurice Perol
Session: Proffered Paper session 1
Resources:
Slides
Webcast
Lung cancer screening: Nodule detection on regular care CT scans
Presenter: Joachim Aerts
Session: Lung cancer screening
Resources:
Slides
Webcast
EGFR mutations: Beyond TKIs - integrating bipsecifics and ADCs
Presenter: Sanjay Popat
Session: Innovation in actionable genomic alterations (AGA)
Resources:
Slides
Webcast
ALK Fusions: Where do we go after lorlatinib?
Presenter: Geoffrey Liu
Session: Innovation in actionable genomic alterations (AGA)
Resources:
Slides
Webcast
Lung cancer screening in never smokers
Presenter: Yeun-Chung Chang
Session: Lung cancer screening
Resources:
Slides
Webcast